Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC -

Sales of popular weight loss drug Wegovy more than doubled to 9.38 billion kroner.

Related Articles

Latest in News

More from CNBC | Breaking News: Markets Pharmaceuticals Earnings Novo Nordisk A S Breaking News: Europe Markets business news cnbc Articles Companies Investing source:tagname:CNBC Europe Source